Daily Stock Analysis, BNTC, Benitec Biopharma Ltd, priceseries

Benitec Biopharma Ltd. Daily Stock Analysis
Stock Information
Open
6.14
Close
5.69
High
6.14
Low
5.29
Previous Close
5.89
Daily Price Gain
-0.20
YTD High
17.41
YTD High Date
Feb 7, 2020
YTD Low
4.14
YTD Low Date
Mar 16, 2020
YTD Price Change
-1.28
YTD Gain
-18.42%
52 Week High
17.41
52 Week High Date
Feb 7, 2020
52 Week Low
4.14
52 Week Low Date
Mar 16, 2020
52 Week Price Change
-4.97
52 Week Gain
-46.63%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 13. 2017
27.72
Jan 23. 2017
29.61
5 Trading Days
6.82%
Link
LONG
Mar 29. 2017
39.85
Apr 6. 2017
44.01
6 Trading Days
10.44%
Link
LONG
Oct 2. 2017
32.51
Oct 6. 2017
36.64
4 Trading Days
12.70%
Link
LONG
Oct 11. 2017
36.86
Oct 13. 2017
39.78
2 Trading Days
7.93%
Link
LONG
Oct 17. 2017
41.50
Oct 18. 2017
44.50
1 Trading Days
7.22%
Link
LONG
Jan 3. 2018
44.95
Jan 22. 2018
53.14
12 Trading Days
18.23%
Link
LONG
Jul 3. 2018
32.55
Jul 16. 2018
42.77
8 Trading Days
31.41%
Link
LONG
Feb 22. 2019
24.75
Mar 13. 2019
29.28
13 Trading Days
18.31%
Link
LONG
Jul 31. 2019
12.75
Aug 1. 2019
14.48
1 Trading Days
13.53%
Link
LONG
Dec 30. 2019
7.00
Jan 2. 2020
7.51
2 Trading Days
7.28%
Link
LONG
Feb 5. 2020
7.69
Feb 10. 2020
8.56
3 Trading Days
11.26%
Link
LONG
Apr 20. 2020
13.06
Apr 22. 2020
13.99
2 Trading Days
7.12%
Link
Company Information
Stock Symbol
BNTC
Exchange
NasdaqCM
Company URL
http://www.benitec.com
Company Phone
-
CEO
Gregory C. West
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
-
About

Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene-silencing technology called ddRNAi or RNAi. It operates through the Australia and United States of America geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in Melbourne, Australia.

Description

Developing gene therapies for hepatitis C based on RNA interference.